Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GSK, MaRS Innovation partner on translational research
July 2011
SHARING OPTIONS:

TORONTO—GlaxoSmithKline Inc. and MaRS Innovation have created a new development fund to support and fast-track commercialization for translational research originating from 16 leading academic health sciences centers, hospitals and universities. The fund will provide support for projects with strong commercialization potential in the areas of diagnostics, drug development and healthcare delivery technologies, and representatives from both organizations will choose projects for development under the three-year partnership. The fund will offer access to capital and opportunities to engage with drug-development experts to position technologies for commercialization through licensing transactions and/or start-up company creation.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.